Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Observational Study in Males With Hemophilia A

NCT03876301 is registered in ClinicalTrials.gov with Spark Therapeutics, Inc. as lead sponsor.

NCT NCT03876301
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03876301 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Observational Study in Males With Hemophilia A
Lead sponsor
Spark Therapeutics, Inc.
Phase
Observational
Overall status
Completed
Start date
January 21, 2019
Completion date
May 2, 2023
Enrollment
25 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

blood coagulation disorder, blood coagulation disorders, inherited, coagulation protein disorders, factor viii deficiency, genetic diseases, inborn, genetic diseases, x-linked, hematologic diseases, hemophilia a, hemorrhagic disorders